Pharmacology

Action Mechanism of Action Reference
INHIBITOR Mannan-binding lectin serine protease 2 inhibitor Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glomerulonephritis, IGA 3 D005922 ClinicalTrials
Atypical Hemolytic Uremic Syndrome 3 D065766 ClinicalTrials
Lupus Nephritis 2 D008181 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298195
FDA SRS FT24ZQQ5RP